Citations

Showing 10 of 108119 citations.

Biomarker analysis from a Phase I study of copanlisib with expansion cohorts in solid tumors with and without PIK3CA mutations and NHL.
Peña, Carol E. , Jeffers, Michael , Genvresse, Isabelle , Ramanathan, Ramesh K., Patnaik, Amita , Appleman, Leonard J.

Mayo Clinic

Journal of Clinical Oncology | March 7, 2019 | Volume: 33 | Issue: 15_suppl | Pages: 2548-2548

10.1200/jco.2015.33.15_suppl.2548 Get It

A phase I trial of the safety and immunogenicity of a multi-epitope folate receptor alpha peptide vaccine used in combination with cyclophosphamide in subjects previously treated for breast or ovarian cancer.
Kalli, Kimberly R., Block, Matthew S. , Hobday, Timothy J. , Dockter, Travis , Erskine, Courtney L. , Visscher, Daniel W., Wilson, G. Haswell , Shreeder, Barath , Knutson, Keith L. , Kasi, Pashtoon Murtaza , Suman, Vera J. , Wilson, Glynn, Knutson, Keith L.

Mayo Clinic

Journal of Clinical Oncology | March 7, 2019 | Volume: 33 | Issue: 15_suppl | Pages: e14028-e14028

10.1200/jco.2015.33.15_suppl.e14028 Get It

Delineation of MGMT promoter hypermethylation as a predictive biomarker for the A071102 clinical trial of veliparib combined with temozolomide (TMZ) using patient-derived xenograft (PDX) GBM models.
Kizilbash, Sani H. , Carlson, Brett L. , Decker, Paul A. , Eckel‐Passow, Jeanette E. , Kitange, Gaspar J. , Jenkins, Robert B. , Kizilbash, Sani H , Sarkaria, Jann N. , Gupta, Shiv K. , Mladek, Ann C. , Bakken, Katrina K. , Schroeder, Mark A. , Decker, Paul A. , Sulman, Erik P.

Mayo Clinic

Journal of Clinical Oncology | March 7, 2019 | Volume: 33 | Issue: 15_suppl | Pages: 2052-2052

10.1200/jco.2015.33.15_suppl.2052 Get It

NCCTG N0872 (Alliance): A randomized placebo-controlled phase II trial of bevacizumab plus dasatinib in patients with recurrent glioblastoma (GBM).
Anderson, S. Keith , Anastasiadis, P, Tran, David , Jeyapalan, Suriya, Anderson, Daniel M. , Buckner, Jan C. , Schiff, David , Galanis, Evanthia , Anastasiadis, Panagiotis, Tran, David D. , Kaufmann, Timothy J. , Giannini, Caterina

Mayo Clinic

Journal of Clinical Oncology | March 7, 2019 | Volume: 33 | Issue: 15_suppl | Pages: 2004-2004

10.1200/jco.2015.33.15_suppl.2004 Get It

Results of NRG oncology/RTOG 9813: A phase III randomized study of radiation therapy (RT) and temozolomide (TMZ) versus RT and nitrosourea (NU) therapy for anaplastic astrocytoma (AA).
Chang, Susan M. , Cairncross, J. Gregory , Bahary, Jean-Paul , Dolinskas, Carol A., Aldape, Kenneth , Schiff, David , Jaeckle, Kurt A. , Brown, Paul D. , Barger, Geoffrey, Werner‐Wasik, Maria, Brachman, David, Peñas-Prado, Marta , Robins, H. Ian, Bélanger, Karl, Schultz, Christopher J. , Zhang, Peixin, Gilbert, Mark R. , Chakravarti, Arnab , Shih, Helen A. , Mehta, Minesh P.

Mayo Clinic

Journal of Clinical Oncology | March 7, 2019 | Volume: 33 | Issue: 15_suppl | Pages: 2002-2002

10.1200/jco.2015.33.15_suppl.2002 Get It

Novel algorithms to predict the occurrence of in-hospital venous thromboembolism in cancer patients: Machine learning classifiers developed from the 2012 national inpatient sample.
Mody, Kabir , Shatzel, Joseph J. , James, Spencer L.

Mayo Clinic

Journal of Clinical Oncology | March 7, 2019 | Volume: 33 | Issue: 15_suppl | Pages: 1582-1582

10.1200/jco.2015.33.15_suppl.1582 Get It

Alcohol consumption and prognosis in patients with stage III colon cancer: A correlative analysis of phase III trial NCCTG N0147 (Alliance).
Phipps, Amanda I. , Nelson, Garth D. , Chan, Emily , Goldberg, Richard M. , Kahlenberg, Morton S., Nair, Suresh , Shields, Anthony F. , Shi, Qian , Limburg, Paul J. , Sargent, Daniel J. , Sinicrope, Frank A. , Gill, Sharlene , Newcomb, Polly A. , Alberts, Steven R.

Mayo Clinic

Journal of Clinical Oncology | March 7, 2019 | Volume: 33 | Issue: 15_suppl | Pages: 1508-1508

10.1200/jco.2015.33.15_suppl.1508 Get It

The screening of breast cancer awareness and health behaviors of women age 40 to 69 in Mus, the least developed city in Turkey: A population based, cross-sectional study.
Yuce, Salih, Guler, Tekin, Ulun, Canan, Ozaydin, Nilufer, Pruthi, Sandhya , Karabulut, Koray , Özmen, Tolga , Ozaydin, Nilufer, Akkapulu, Nezih , Özmen, Vahit

Mayo Clinic

Journal of Clinical Oncology | March 7, 2019 | Volume: 33 | Issue: 15_suppl | Pages: e12569-e12569

10.1200/jco.2015.33.15_suppl.e12569 Get It

Role of β blocker and angiotensin antagonist for the prophylaxis of early onset anthracycline-induced ventricular dysfunction: A meta-analysis of five randomized controlled trials.
Vincelette, Nicole D. , Yun, Seongseok

Mayo Clinic

Journal of Clinical Oncology | March 7, 2019 | Volume: 33 | Issue: 15_suppl | Pages: 1021-1021

10.1200/jco.2015.33.15_suppl.1021 Get It

Phase III trial of etirinotecan pegol (EP) versus Treatment of Physician’s Choice (TPC) in patients (pts) with advanced breast cancer (aBC) whose disease has progressed following anthracycline (A), taxane (T) and capecitabine (C): The BEACON study.
Perez, Edith A. , O’Shaughnessy, Joyce , Twelves, Chris , Zhao, Carol, Hoch, Ute , Hannah, Alison L., Awada, Ahmad , Rugo, Hope S. , Im, Seock‐Ah , Cortés, Javier

Mayo Clinic

Journal of Clinical Oncology | March 7, 2019 | Volume: 33 | Issue: 15_suppl | Pages: 1001-1001

10.1200/jco.2015.33.15_suppl.1001 Get It